JD Supra

Federal Court orders Minister of Health to issue NOC to Fresenius Kabi for its biosimilar IDACIO following filing of consent letter

On October 29, 2020, Justice Manson of the Federal Court ordered the Minister of Health to issue a notice of compliance (NOC) to Fresenius Kabi for IDACIO (adalimumab), a biosimilar of AbbVie’s HUMIRA ...
Monthly Prescribing Reference

Idacio, a Citrate-Free Biosimilar to Humira, Gets FDA Approval

Safety, tolerability through 24 months was consistent with 12-month tofacitinib analysis. The approval for Idacio was based on a review of data that showed similar pharmacokinetics, efficacy, safety, ...
Medscape

FDA Approves Idacio as Eighth Adalimumab Biosimilar in US

A biosimilar drug to the tumor necrosis factor inhibitor adalimumab, marketed as Idacio (adalimumab-aacf), has been approved by the Food and Drug Administration for use in the United States, according ...
Healio

Top in rheumatology: Adalimumab biosimilar approval; the immunopathophysiology of PsA

Please provide your email address to receive an email when new articles are posted on . The FDA approved Idacio as a biosimilar to Humira, a TNF inhibitor with indications for rheumatoid arthritis, ...
Medindia

U.S. FDA Approves Eighth Adalimumab

Adalimumab injection products are used to relieve the symptoms of certain autoimmune disorders Humira is the brand name of the original adalimumab medicine, which is used as reference FDA has approved ...
Healio

FDA approves Fresenius Kabi’s Idacio as eighth adalimumab biosimilar

Please provide your email address to receive an email when new articles are posted on . The FDA has approved Idacio as the eighth biosimilar to adalimumab, for all eligible indications of the ...